Series date: 
01/01/2025 - 8:00am CST to 12/31/2025 - 11:59pm CST

Program Overview: This is an independent study for pediatric nurses that care for oncology hematology patients that provides topics that will increase knowledge and awareness of this population. 

Course Director/Contact:

  • Kristine Hoelle, MSN, RN, CPHON, CPN; Nursing Professional Development Specialist, Pediatric Hematology/Oncology, Advocate Christ Hospital, Advocate Health Midwest

Overall Objectives:

  1. This is an independent study for pediatric nurses that care for oncology hematology patients that provides topics that will increase knowledge and awareness of this population. 

Target Audience:  
This activity is designed for Pediatric hematology oncology nurses.

Disclosure

The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.

 

Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Statement(s)

American Nurses Credentialing Center (ANCC) 
Advocate Health designates this enduring activity for a maximum of 1.2 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

 

Series location: 
online
United States

Sessions

Session Date
Peds Hem/Onc Independent Study 2025: January: “I Don’t Get to Play With My Mum Anymore”: Experiences of Siblings Aged 8–12 of Children With Cancer: A Qualitative Study 01/01/2025 - 6:00am CST to 01/31/2025 - 11:59pm CST
Peds Hem/Onc Independent Study 2025: February: Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors 02/01/2025 - 6:00am CST to 02/28/2025 - 11:59pm CST
Peds Hem/Onc Independent Study 2025: Month: Topic: DO NOT DELETE OR EDIT THIS SESSION TEMPLATE 02/01/2025 - 6:00am CST to 01/31/2026 - 11:59pm CST
Peds Hem/Onc Independent Study 2025: March: Allopurinol use During Pediatric ALL Maintenance Therapy Corrects Kkewed 6MP Metabolism, Improving Inadequate Myelosuppression and Reducing Gastrointestinal Toxicity 03/01/2025 - 6:00am CST to 03/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025 April: Evaluation of a nausea assessment tool in the pediatric oncology population 04/01/2025 - 6:00am CDT to 04/30/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025 May: Fertility Preservation in Pediatric Leukemia and Lymphoma: A Report from the Children’s Oncology Group 05/01/2025 - 6:00am CDT to 05/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: June: Neuropsychological Performance and Its Predictors in the Early Treatment Phase of Non-CNS Pediatric Cancer 06/01/2025 - 6:00am CDT to 06/30/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: July: Deferiprone Versus Deferoxamine For Transfusional Iron Overload in Sickle Cell Disease and Other Anemias: Pediatric Subgroup Analysis of the Randomized, Open-label FIRST Study 07/01/2025 - 12:00am CDT to 07/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: August: Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk 08/01/2025 - 12:00am CDT to 08/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: September: Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics in a Nursing Staff 09/01/2025 - 12:01am CDT to 09/30/2025 - 11:59pm CDT

Pages